Pain, Chronic Clinical Trial
— PAWOfficial title:
Pain and Weight Treatment: Development and Trial of PAW
Pediatric weight management efficacy is impacted by failure to complete treatment protocols and, for those that do complete treatment, a return to unhealthy behaviors. This project tests whether treating pain, a common comorbid condition to pediatric obesity, will enhance treatment. This study will generate results that can be translated into immediate improvements in care for families seeking treatment for pediatric obesity.
| Status | Recruiting |
| Enrollment | 50 |
| Est. completion date | May 2025 |
| Est. primary completion date | May 2025 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 12 Years to 18 Years |
| Eligibility | Inclusion Criteria: - Males and females between 12 and 18 years of age - Ability to speak, write and read English - A parent or guardian who speaks, writes and reads English - Signed consent and assent from the child and parent - Enrollment in a weight management program - Score greater than 3 on the Pain Burden Inventory at screening (in order to recruit adolescents who experience more than just general aches and pains). - Youth reporting musculoskeletal pain Exclusion Criteria: - Parent or guardian unable to participate - Patients on weight reducing medications - Severe psychiatric illness (i.e., suicidal or hospitalization within past 6 months) - Medical conditions such as Type 1 diabetes |
| Country | Name | City | State |
|---|---|---|---|
| United States | Connecticut Children's Medical Center | Hartford | Connecticut |
| Lead Sponsor | Collaborator |
|---|---|
| Connecticut Children's Medical Center | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Mean difference in session attendance between groups | The number of sessions of fit5 attended will be compared between the group attending PAW and those in the information control group. | Through the 13 weeks that comprise fit5 | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined Via exit interviews | At the exit interviews, we will inquire with families whether 4 sessions felt sufficient, whether they would have liked more or less sessions and when they would have liked sessions scheduled. | At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Depressed mood: The Center for Epidemiological Studies Depression Scale for Children (CES-DC) |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Eating behaviors (EAH): Three Factor Eating Questionnaire - R18 |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Pain Frequency - Severity - Duration Scale |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Adolescent Pediatric Pain Tool |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Self-confidence: Readiness Ruler |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Eating behaviors: Eating Behaviors Questionnaire |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Behavior: The Pediatric Symptom Checklist 17 item (PSC-17) |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Quality of life: Sizing me up |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Quality of life: Sizing them up |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Child Activity Limitations Interview questionnaire |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Child Activity Limitations Interview questionnaire Parent version |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: Pain Burden Interview |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Sleep: Adolescent Sleep-Wake Scale |
At the conclusion of the 13 weeks of the program | |
| Secondary | The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. | Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Medical: Youth will have their height, weight, BMI and BMI z-score calculated pre and post program completion as well as an assessment of their medical comorbidities. |
At the conclusion of the 13 weeks of the program |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05452499 -
Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae
|
N/A | |
| Recruiting |
NCT05037682 -
Pain and Opioid Management in Older Adults
|
N/A | |
| Completed |
NCT04080037 -
Assessing Opioid Care Practices Using CPV Patient Simulation Modules
|
N/A | |
| Recruiting |
NCT05382962 -
iCanCope With Post-Operative Pain (iCanCope PostOp)
|
N/A | |
| Recruiting |
NCT04285112 -
SPRINT: Signature for Pain Recovery IN Teens
|
||
| Active, not recruiting |
NCT04850079 -
EHR Precision Drug Treatment in Neonates
|
||
| Completed |
NCT03271151 -
Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty
|
Phase 4 | |
| Completed |
NCT03272139 -
Interscalene Block Versus Superior Trunk Block
|
Phase 4 | |
| Completed |
NCT03886142 -
Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis
|
N/A | |
| Recruiting |
NCT05761392 -
APP-based Precise Management System of Chronic Intractable Pain
|
N/A | |
| Recruiting |
NCT05877157 -
Pain AND Opioids After Surgery
|
||
| Completed |
NCT03947749 -
Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
|
||
| Completed |
NCT03280017 -
Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain
|
Phase 4 | |
| Recruiting |
NCT04874038 -
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
|
Phase 3 | |
| Completed |
NCT04280796 -
Changes in Affective Pain Processing in Human Volunteers
|
N/A | |
| Withdrawn |
NCT05125978 -
Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain
|
Phase 2 | |
| Not yet recruiting |
NCT04328805 -
Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.
|
Phase 4 | |
| Completed |
NCT04976738 -
A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
|
Phase 1/Phase 2 | |
| Completed |
NCT04089618 -
Meditation Based Lifestyle Modification in Chronic Pain
|
N/A | |
| Recruiting |
NCT05699837 -
Alpha Entrainment for Pain and Sleep (Extension)
|
N/A |